KERX - Keryx Biopharmaceuticals, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts7777
Avg. Estimate-0.18-0.16-1.23-0.32
Low Estimate-0.21-0.18-1.36-0.39
High Estimate-0.15-0.12-0.7-0.25
Year Ago EPS-0.39-0.32-1.52-1.23
Revenue EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts7788
Avg. Estimate18.04M22.32M69.22M138.7M
Low Estimate14.14M19.14M65.57M105.79M
High Estimate19.26M23.56M74.37M185.7M
Year Ago Sales6.34M9.53M31.98M69.22M
Sales Growth (year/est)184.70%134.10%116.40%100.40%
Earnings History9/29/201612/30/20163/30/20176/29/2017
EPS Est.-0.2-0.25-0.2-0.18
EPS Actual-0.39-0.32-0.21-0.77
Difference-0.19-0.07-0.01-0.59
Surprise %-95.00%-28.00%-5.00%-327.80%
EPS TrendCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Current Estimate-0.18-0.16-1.23-0.32
7 Days Ago-0.18-0.16-1.23-0.32
30 Days Ago-0.18-0.16-1.23-0.32
60 Days Ago-0.18-0.16-1.23-0.32
90 Days Ago-0.16-0.14-0.69-0.23
EPS RevisionsCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesKERXIndustrySectorS&P 500
Current Qtr.53.80%N/AN/A0.17
Next Qtr.50.00%N/AN/A0.27
Current Year19.10%N/AN/A0.07
Next Year74.00%N/AN/A0.12
Next 5 Years (per annum)116.20%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A